keyword
MENU ▼
Read by QxMD icon Read
search

MDA5 antibody Interstitial lung disease

keyword
https://www.readbyqxmd.com/read/30463865/effect-of-plasma-exchange-on-antifactor-xa-activity-of-enoxaparin-and-serum-levetiracetam-levels
#1
Bradley J Peters, Mikaela Hofer, Craig E Daniels, Jeffrey L Winters
PURPOSE: The effect of therapeutic plasma exchange (TPE) on antifactor Xa activity in a patient treated with enoxaparin and levetiracetam is reported. SUMMARY: A 52-year-old woman was treated with levetiracetam and prophylactic enoxaparin while receiving TPE to manage respiratory failure due to anti-MDA5 antibody-associated interstitial lung disease (ILD) with dermatomyositis. Due to a scant amount of evidence regarding the management of these medications in TPE, therapeutic monitoring principles were used to assess the effect TPE had on these medications...
December 1, 2018: American Journal of Health-system Pharmacy: AJHP
https://www.readbyqxmd.com/read/30461626/coexistence-of-anti-hmgcr-and-anti-mda5-identified-by-an-unlabeled-immunoprecipitation-assay-in-a-chinese-patient-cohort-with-myositis
#2
Li Huang, Li Wang, Yang Yang, Huan Chen, Yanjuan Liu, Ke Liu, Meidong Liu, Yizhi Xiao, Xiaoxia Zuo, Yisha Li, Hui Luo, Huali Zhang, Xianzhong Xiao
Myositis-specific autoantibodies are important diagnostic and prognostic markers. The aim of our study is to detect anti-3-hydroxy 3-methylutaryl coenzyme A reductase (anti-HMGCR) antibody using novel unlabeled immunoprecipitation (IP) assay and immunoblotting in Chinese patients with myositis and to clarify the features of anti-HMGCR-positive patients. In the present study, we established novel unlabeled IP assay and immunoblotting of HMGCR C-terminus for anti-HMGCR detection. The presence of anti-HMGCR was screened in 181 Chinese patients with myositis...
November 2018: Medicine (Baltimore)
https://www.readbyqxmd.com/read/30449789/clinical-features-of-anti-mda5-antibody-positive-rapidly-progressive-interstitial-lung-disease-without-signs-of-dermatomyositis-a-case-series
#3
Noriho Sakamoto, Hiroshi Ishimoto, Shota Nakashima, Hirokazu Yura, Takuto Miyamura, Daisuke Okuno, Atsuko Hara, Takeshi Kitazaki, Tomoyuki Kakugawa, Yuji Ishimatsu, Minoru Satoh, Hiroshi Mukae
Anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibody is associated with rapidly progressive interstitial lung disease (RP-ILD) in patients with clinically amyopathic dermatomyositis (CADM) or dermatomyositis (DM). We herein report three Japanese cases of anti-MDA5 antibody-positive RP-ILD without signs of CADM or DM. High-resolution computed tomography revealed patchy or subpleural distribution of consolidations and/or ground-glass opacities accompanied by traction bronchiectasis. All patients succumbed to respiratory failure within two months...
November 19, 2018: Internal Medicine
https://www.readbyqxmd.com/read/30449228/serum-neopterin-as-well-as-ferritin-soluble-interleukin-2-receptor-kl-6-and-anti-mda5-antibody-titer-provide-markers-of-the-response-to-therapy-in-patients-with-interstitial-lung-disease-complicating-anti-mda5-antibody-positive-dermatomyositis
#4
Aki Nishioka, Shinichiro Tsunoda, Takeo Abe, Takahiro Yoshikawa, Miki Takata, Masayasu Kitano, Kiyoshi Matsui, Ran Nakashima, Yuji Hosono, Koichiro Ohmura, Tsuneyo Mimori, Hajime Sano
OBJECTIVE: This study identified biomarkers that can be used to assess disease activity and response to therapy in patients with interstitial lung disease complicating anti-melanoma differentiation-associated gene 5 (MDA5) antibody (Ab)-positive clinically amyopathic dermatomyositis (CADM). METHODS: In 15 patients with interstitial lung disease complicating anti-MDA5 Ab-positive CADM, anti-MDA5 Ab, neopterin, interleukin (IL)-18, ferritin, and soluble interleukin 2 receptor (sIL-2R) levels were measured in cryopreserved serum specimens before and at multiple times after remission induction therapy, and their correlations were assessed...
November 19, 2018: Modern Rheumatology
https://www.readbyqxmd.com/read/30382445/anti-mda5-antibody-spectrum-in-western-world
#5
REVIEW
Siamak Moghadam-Kia, Chester V Oddis, Rohit Aggarwal
PURPOSE OF REVIEW: Anti-melanoma differentiation-associated gene 5 (anti-MDA5) is a novel and highly specific myositis-associated autoantibody, which defines a unique phenotype among patients with dermatomyositis (DM). RECENT FINDINGS: Anti-MDA5 was originally characterized in Japan in DM patients with hallmark cutaneous features and no proximal muscle weakness and termed clinically amyopathic DM (CADM). Anti-MDA5 has characteristic cutaneous manifestations which include tender palmar papules and cutaneous ulcerations, along with an increased frequency of interstitial lung disease (ILD) that can be rapidly progressive (RPILD) and fatal...
October 31, 2018: Current Rheumatology Reports
https://www.readbyqxmd.com/read/30333415/rheumatoid-arthritis-complicated-with-anti-melanoma-differentiation-associated-gene-5-antibody-positive-interstitial-pneumonia-a-case-report
#6
Haruki Matsumoto, Shuzo Sato, Yuya Fujita, Makiko Yashiro-Furuya, Naoki Matsuoka, Tomoyuki Asano, Hiroko Kobayashi, Hiroshi Watanabe, Kiyoshi Migita
Anti-melanoma differentiation-associated gene 5 (MDA5) antibodies are frequently detected in amyopathic dermatomyositis with rapidly progressive interstitial lung disease (RP-ILD). However, the presence of anti-MDA5 antibodies in other connective tissue diseases is not well known. We herein report a case of rheumatoid arthritis complicated with refractory anti-MDA5 antibody-positive ILD. A 75-year-old Japanese woman was referred to our hospital for refractory ILD. Serological testing was positive for anti-MDA5 antibody without any muscle or skin lesions...
October 17, 2018: Internal Medicine
https://www.readbyqxmd.com/read/30285929/-dermatomyositis-associated-with-anti-mda5-autoantibody
#7
María Victoria Collado, María De Los Ángeles Gargiulo, Ramiro Gómez, Graciela Gómez, Nicolás Pérez, Lorena Suarez, Ana Lía Taratuto, Patricia Aruj
Dematomyositis is an idiopathic inflammatory myopathy with a variable clinical spectrum. In recent years, a number of myositis-specific antibodies have been identified including anti-MDA5, which is us eful for diagnosis, prognosis and classification of the diverse clinical forms of the disease. This antibody is associated with cutaneous ulcers, rapidly progressive interstitial lung disease, early mortality and poor prognosis, so the detection of this antibody in a suitable clinical context, raises the need for an aggressive immunosuppressive treatment...
2018: Medicina
https://www.readbyqxmd.com/read/30158335/anti-mda5-antibody-positive-hypomyopathic-dermatomyositis-complicated-with-pneumomediastinum
#8
Makiko Yashiro, Tomoyuki Asano, Shuzo Sato, Hiroko Kobayashi, Hiroshi Watanabe, Masayuki Miyata, Kiyoshi Migita
Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive clinically amyopathic dermatomyositis (CADM) is frequently associated with rapidly progressive interstitial lung disease (RP-ILD) resulting in high mortality. Here we report a 51-year-old Japanese woman with anti-MDA5 antibody-positive hypomyopathic dermatomyositis (DM) who developed RP-ILD. She developed respiratory failure and pneumomediastinum, however her RP-ILD responded favorably to the combined immunosuppressive treatments consisting of steroids, intravenous cyclophosphamide and tacrolimus...
2018: Fukushima Journal of Medical Science
https://www.readbyqxmd.com/read/30150008/low-positive-titer-of-anti-melanoma-differentiation-associated-gene-5-antibody-is-not-associated-with-a-poor-long-term-outcome-of-interstitial-lung-disease-in-patients-with-dermatomyositis
#9
Satoshi Sakamoto, Masaki Okamoto, Shinjiro Kaieda, Kiminori Fujimoto, Shuji Nagata, Masaki Tominaga, Masayuki Nakamura, Yoshiaki Zaizen, Takashi Nouno, Takuma Koga, Tomotaka Kawayama, Masataka Kuwana, Hiroaki Ida, Tomoaki Hoshino
BACKGROUND: Anti-melanoma differentiation-associated gene 5 antibody (anti-MDA5-Ab) is associated with fatal rapidly progressive interstitial lung disease (RP-ILD) in patients with dermatomyositis (DM). We attempted to clarify whether anti-MDA5-Ab is associated with long-term outcomes in patients with DM-ILD. METHODS: Thirty-six patients with DM-ILD were retrospectively analyzed for their serum anti-MDA5-Ab by using an enzyme-linked immunosorbent assay. We analyzed the association between clinical parameters, including the serum levels of anti-MDA5-Ab and ferritin...
November 2018: Respiratory Investigation
https://www.readbyqxmd.com/read/30138971/-the-clinical-significance-of-myositis-specific-antibodies-in-polymyositis-dermatomyositis-associated-interstitial-lung-diseases
#10
M M Xie, X Yan, H Li, J J Ding, X H Gui, Y Liu, Y S Wang, Z Y Chen, H R Cai
Objective: To investigate the profile and clinical significance of myositis-specific antibody spectrum (MSAs) in patients with polymyositis/dermatomyositis-associated interstitial lung disease (PM/DM-ILD). Methods: Sera from 74 patients with PM/DM-ILD, 29 patients with SLE and 32 healthy controls were collected and Euroline Autoimmune Inflammatory Myopathies 16 Ag kit was used for detecting MSAs . The clinical data of all patients were collected from medical records. Statistical analysis was performed using One-way ANOVA, t -test, rank sum test, χ(2) test or Fisher's exact test...
August 12, 2018: Chinese Journal of Tuberculosis and Respiratory Diseases
https://www.readbyqxmd.com/read/30101523/measurement-of-cytokines-and-chemokines-and-association-with-clinical-severity-of-dermatomyositis-and-clinically-amyopathic-dermatomyositis
#11
M Chen, C Quan, L Diao, F Xue, K Xue, B Wang, X Li, X Zhu, J Zheng, H Cao
BACKGROUND: Dermatomyositis (DM) is an autoimmune disease affecting primarily the skin, muscle and lung. Dysregulations of cytokines and chemokines are commonly found in inflammatory disorders. OBJECTIVES: To investigate the association between serum cytokines and chemokines and clinical severity, especially cutaneous lesions and interstitial lung disease (ILD) in patients with DM and clinically amyopathic DM (CADM). METHODS: Clinical features, laboratory findings and serum of 40 patients with DM or CADM were collected and analysed...
August 12, 2018: British Journal of Dermatology
https://www.readbyqxmd.com/read/30060040/tofacitinib-for-refractory-interstitial-lung-diseases-in-anti-melanoma-differentiation-associated-5-gene-antibody-positive-dermatomyositis
#12
Kazuhiro Kurasawa, Satoko Arai, Yumeko Namiki, Ayae Tanaka, Yuta Takamura, Takayoshi Owada, Masafumi Arima, Reika Maezawa
Objective: We aimed to determine the outcome of combination therapy with tofacitinib (TOF) in a case series of refractory rapidly progressive interstitial lung disease (ILD) associated with anti-melanoma differentiation-associated 5 gene (MDA5) antibody-positive (Ab+) DM. Patients who had poor prognostic factors and failed to respond to immunosuppressive therapy were selected for TOF treatment. Methods: Five patients with anti-MDA5 Ab+ DM-ILD who failed to respond to triple therapy with high dose glucocorticoids, CSA and CYC were given additional TOF (10 mg/day)...
December 1, 2018: Rheumatology
https://www.readbyqxmd.com/read/29984753/anti-mda5-antibody-positive-dermatomyositis-complicated-by-autoimmune-associated-hemophagocytic-syndrome-that-was-successfully-treated-with-immunosuppressive-therapy-and-plasmapheresis
#13
Yuya Fujita, Shoichi Fukui, Takahisa Suzuki, Midori Ishida, Yushiro Endo, Sousuke Tsuji, Ayuko Takatani, Takashi Igawa, Toshimasa Shimizu, Masataka Umeda, Remi Sumiyoshi, Ayako Nishino, Tomohiro Koga, Shin-Ya Kawashiri, Naoki Iwamoto, Kunihiro Ichinose, Mami Tamai, Hideki Nakamura, Tomoki Origuchi, Kuniko Abe, Atsushi Kawakami
A 56-year-old Japanese woman with muscle weakness, increased creatine kinase and aldolase levels, and characteristic cutaneous lesions was diagnosed with anti-melanoma differentiation-associated gene 5 antibody (anti-MDA5 antibody)-positive dermatomyositis. She also had interstitial lung disease (ILD). After corticosteroid and tacrolimus combination therapy was started, pancytopenia and elevated serum ferritin and transaminase emerged. Because the bone marrow tissues were hypoplastic with hemophagocytes, she was diagnosed with concomitant autoimmune-associated hemophagocytic syndrome (HPS)...
July 6, 2018: Internal Medicine
https://www.readbyqxmd.com/read/29957268/differential-clinical-features-of-patients-with-clinically-amyopathic-dermatomyositis-who-have-circulating-anti-mda5-autoantibodies-with-or-without-myositis-associated-autoantibodies
#14
Koichi Yamaguchi, Aya Yamaguchi, Chiharu Kashiwagi, Yuri Sawada, Kohei Taguchi, Kazue Umetsu, Kazuma Oshima, Megumi Uchida, Masafumi Suzuki, Shunichi Kono, Masao Takemura, Hiroaki Masubuchi, Shinsuke Kitahara, Kenichiro Hara, Toshitaka Maeno, Sei-Ichiro Motegi, Yoshinao Muro, Toru Sakairi, Takeshi Hisada, Masahiko Kurabayashi
BACKGROUND: Anti-melanoma differentiation-associated gene 5 (MDA5) autoantibodies have been identified as myositis-specific autoantibodies that are often associated with clinically amyopathic dermatomyositis (CADM) and a poor prognosis due to rapidly progressive interstitial lung disease (RP-ILD) in East Asian patients. Besides anti-MDA5 autoantibodies, patients with CADM may have myositis-associated autoantibodies (MAAs), which characterize other connective tissue diseases such as rheumatoid arthritis and Sjögren's syndrome...
July 2018: Respiratory Medicine
https://www.readbyqxmd.com/read/29952940/recurrence-of-anti-mda5-antibody-positive-clinically-amyopathic-dermatomyositis-after-long-term-remission-a-case-report
#15
Yushiro Endo, Tomohiro Koga, Midori Ishida, Yuya Fujita, Sosuke Tsuji, Ayuko Takatani, Toshimasa Shimizu, Remi Sumiyoshi, Takashi Igawa, Masataka Umeda, Shoichi Fukui, Ayako Nishino, Shin-Ya Kawashiri, Naoki Iwamoto, Kunihiro Ichinose, Mami Tamai, Hideki Nakamura, Tomoki Origuchi, Masataka Kuwana, Yuji Hosono, Tsuneyo Mimori, Atsushi Kawakami
RATIONALE: Among all dermatomyositis (DM) patients, antimelanoma differentiation-associated gene 5 antibody (anti-MDA5 Ab) positive patients have significantly poor short-term mortality, whereas they experience less relapses over the long term after the remission. We report the case of a patient with anti-MDA5 Ab-positive clinically amyopathic dermatomyositis (CADM) with the recurrence of interstitial lung disease (ILD) after 7 years of remission. There has been no case report of an anti-MDA5 Ab-positive DM patient with the recurrence of ILD after 7 years of long-term remission...
June 2018: Medicine (Baltimore)
https://www.readbyqxmd.com/read/29867431/anti-mda5-antibody-positive-dermatomyositis-presenting-with-cellulitis-like-erythema-on-the-mandible-as-an-initial-symptom
#16
Yuki Hattori, Kanako Matsuyama, Tomoko Takahashi, En Shu, Hiroyuki Kanoh, Mariko Seishima
Panniculitis is an uncommon skin eruption observed in patients with dermatomyositis (DM)/clinically amyopathic dermatomyositis (CADM), especially in anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive DM. We present here a 51-year-old Japanese woman with an anti-MDA5 antibody-positive DM who initially had cellulitis-like erythema on her right mandible. Histopathological findings showed a subcutaneous lobular infiltration of lymphocytes. The patient developed typical skin eruptions of DM/CADM, rapidly progressive interstitial lung disease, and severe muscle weakness 2 weeks after the first visit...
May 2018: Case Reports in Dermatology
https://www.readbyqxmd.com/read/29713969/rituximab-for-refractory-rapidly-progressive-interstitial-lung-disease-related-to-anti-mda5-antibody-positive-amyopathic-dermatomyositis
#17
Ho So, Victor Tak Lung Wong, Virginia Weng Nga Lao, Hin Ting Pang, Ronald Man Lung Yip
To report our experience in using rituximab (RTX) for treating refractory rapidly progressive interstitial lung disease (RP-ILD) complicating anti-melanoma differentiation-associated gene 5 antibody (anti-MDA5 Ab)-positive amyopathic dermatomyositis (ADM). Medical records of four ADM patients with refractory RP-ILD treated with RTX therapy were reviewed retrospectively. All four patients were tested positive for anti-MDA5 Ab and failed to respond to high-dose systemic steroid and other intensive immunosuppressive therapies...
July 2018: Clinical Rheumatology
https://www.readbyqxmd.com/read/29657141/association-of-serum-soluble-cd163-with-polymyositis-and-dermatomyositis-especially-in-anti-mda5-antibody-positive-cases
#18
Hidenaga Kawasumi, Yasuhiro Katsumata, Akira Nishino, Shinya Hirahara, Yasushi Kawaguchi, Masataka Kuwana, Hisashi Yamanaka
OBJECTIVE: We elucidated the association of serum soluble CD163 (sCD163) with rapidly progressive interstitial lung disease (RP-ILD), autoantibody profiles, and serum ferritin in patients with polymyositis (PM), classic dermatomyositis (DM), and clinical amyopathic dermatomyositis (CADM). METHODS: Serum sCD163 levels were retrospectively measured by ELISA in patients with PM, classic DM, and CADM, as well as in healthy controls (HC). Repeat sera samples were obtained posttreatment from available patients...
July 2018: Journal of Rheumatology
https://www.readbyqxmd.com/read/29579373/calcinosis-of-the-mandible-in-dermatomyositis
#19
Andrea Fava, Lisa Christopher-Stine
No abstract text is available yet for this article.
August 2018: Arthritis & Rheumatology
https://www.readbyqxmd.com/read/29532710/myositis-specific-autoantibodies-in-japanese-patients-with-juvenile-idiopathic-inflammatory-myopathies
#20
Masahiro Ueki, Ichiro Kobayashi, Shunichiro Takezaki, Yusuke Tozawa, Yuka Okura, Masafumi Yamada, Masataka Kuwana, Tadashi Ariga
OBJECTIVES: The aim of our study is to clarify the association of myositis-specific autoantibodies (MSAs) with clinical and laboratory features in Japanese patients with juvenile idiopathic inflammatory myopathies (JIIMs). METHODS: We retrospectively analyzed the frequency of MSAs and their association with clinical or laboratory findings in 25 Japanese patients with JIIMs in Hokkaido district. RESULTS: Eighteen of the 25 patients (72%) were positive for MSAs; seven with anti-melanoma differentiation associated gene (MDA) 5 (28%), five with anti-transcriptional intermediary factor (TIF)-1γ (20%), four with anti-MJ/nuclear matrix protein (NXP)-2 (16%), two with anti-Jo-1 (8%), one with anti- HMG-CoA reductase, one with anti-signal recognition peptide (SRP) antibodies (4% each), including co-existence and transition of MSAs in one patient each...
April 9, 2018: Modern Rheumatology
keyword
keyword
162607
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"